$ACTC Ocata Therapeutics, Inc. Insider Trading Week 37/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocata Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocata Therapeutics, Inc. in week 37/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 16 2014 | ACTC | Ocata Therapeutics ... | Anglade Eddy | EVP of Clinical Dev ... | Option Exercise | A | 8.49 | 112,000 | 950,880 | 212,000 | |
Sep 16 2014 | ACTC | Ocata Therapeutics ... | Anglade Eddy | EVP of Clinical Dev ... | Grant | A | 0.00 | 56,000 | 0 | 56,000 | 0 to 56 K |
Sep 16 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | A | 8.49 | 112,000 | 950,880 | 124,858 | |
Sep 16 2014 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Grant | A | 0.00 | 56,000 | 0 | 231,509 | 175.5 K to 231.5 K (+31.91 %) |
Sep 16 2014 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO and CFO | Option Exercise | A | 8.49 | 112,000 | 950,880 | 252,000 | |
Sep 16 2014 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO and CFO | Grant | A | 0.00 | 56,000 | 0 | 56,000 | 0 to 56 K |